COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 730: Articles 7291-7300  | Next

Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
Tannous, J., Pan, A., Potter, T., Bako, A., Dlouhy, K., Drews, A., Sostman, H. D., Vahidy, F.
10.1101/2022.06.30.22277105 — Posted: 2022-07-02
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
Polvere, J., Fabbiani, M., Pastore, G., Rancan, I., Rossetti, B., Durante, M., Zirpoli, S., Morelli, E., Pettini, E., Lucchesi, S., Fiorino, F., Tumbarello, M., Ciabattini, A., Montagnani, F., Medaglini, D.
10.1101/2022.07.01.22277132 — Posted: 2022-07-02
CovidOutcome2: a tool for SARS-CoV2 mutation identification and for disease severity prediction
Kalcsevszki, R., Horvath, A., Gyorffy, B., Pongor, S., Ligeti, B.
10.1101/2022.07.01.496571 — Posted: 2022-07-01
Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children
Lambert, N., Jonas, K.-O. A., Rissy, W. M., Diane, U., Murithi, K., Peter, K., Awe, O. I., Dillman, A.
10.1101/2022.06.30.498338 — Posted: 2022-07-01
Teaching the Skills and Concepts of Gene Expression Analysis during COVID-19
Roberts, L. A., Shell, S. S.
10.1101/2022.06.28.497969 — Posted: 2022-06-30
Identification and Mechanistic Basis of non-ACE2 Blocking Neutralizing Antibodies from COVID-19 Patients with Deep RNA Sequencing and Molecular Dynamics Simulations
Fredericks, A. M., East, K. W., Shi, Y., Liu, J., Maschietto, F., Ayala, A., Cioffi, W. G., Cohen, M., Fairbrother, W. G., Lefort, C. T., Nau, G. J., Levy, M. M., Wang, J., Batista, V. S., Lisi, G. P., Monaghan, S. F.
10.1101/2022.06.29.498206 — Posted: 2022-06-30
Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes
Giurini, E. F., Williams, M., Morin, A., Zloza, A., Gupta, K. H.
10.1101/2022.06.30.498305 — Posted: 2022-06-30
Influenza and pneumococcal vaccination and the risk of COVID-19: A systematic review and meta-analysis
Kapoula, G. V., Vennou, K. E., Bagos, P. G.
10.1101/2022.06.30.22277089 — Posted: 2022-06-30
The Citation of Retracted COVID-19 Papers is Common and Rarely Critical
Meyerowitz-Katz, G., Sekhar, P., Besancon, L., Turner, T., McDonald, S.
10.1101/2022.06.30.22277084 — Posted: 2022-06-30
Chronic fatigue, depression and anxiety symptoms in Long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection.
Al-Hakeim, H. K., Al-Rubaye, H. T., Almulla, A. F., Al-Hadrawi, D. S., Maes, M. F.
10.1101/2022.06.29.22277056 — Posted: 2022-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).